ENTITY

Repligen Corp (RGEN US)

16
Analysis
Health Care • United States
Repligen Corporation is a bioprocessing company focused on the development, production, and commercialization of innovative products used in the process of manufacturing biologic drugs. The Company's customers include life sciences companies, global biopharmaceutical companies, and contract manufacturers worldwide.
more
Company Event • 27 Oct 2026 20:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 19 Feb 2027 01:30 • Upcoming
Add To Calendar

Q4 2026

Company Event • 10 Sep 2026 01:30 • Latest

Wells Fargo 21st Annual Healthcare Conference

Company Event • 28 Jul 2026 20:00

Q2 2026

Company Event • 22 Jul 2026 20:30

M&A announcement

x